Growth in medtech is a success story not a drain on resources, says US institute
This article was originally published in Clinica
Executive Summary
Peter Orszag, during his tenure as director of the Congressional Budget Office (CBO), played up analyst reports in 2007 that the rise in healthcare spending in the US was predominantly down to the “development and diffusion” of new medical technology.
You may also be interested in...
US: The sun shines in on industry-doctor relationships
The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean
Global regulators/industry to gather in US and Germany to talk device regulation
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.
Global regulators and industry execs to gather in US and Germany to talk device regulation
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.